Constellation Pharmaceuticals attracts $100 mln

Cambridge, Massachusetts-based Constellation Pharmaceuticals Inc, a developer of tumor-targeted and immuno-oncology therapies, has raised $100 million in financing. The investors included Cormorant Asset Management, Deerfield Management, Fidelity Management and Research Company, Hillhouse Capital, NS Investment, OrbiMed, Sirona Capital, Venrock Healthcare Partners, The Column Group, Third Rock Ventures, Venrock, SROne, University of California Investment Office, Topspin Partners and Casdin Capital.

Source: Press Release